Dennis Scanlon is a Distinguished Professor of Health Policy and Administration and the director of the Center for Health Care and Policy Research. Scanlon’s research focuses on the role of quality improvement and incentives in changing healthcare outcomes such as clinical quality, patient experience, and economic efficiency.
During the COVID-19 pandemic, Scanlon has been providing public commentary on the regulatory process in the United States for testing the COVID-19 vaccine candidates to determine their efficacy and effectiveness and on how an Emergency Use Authorization can help speed up the approval for expedited distribution to the population. He has also commented on the ethical issues and other potential challenges faced in distributing a limited vaccine supply in the United States and globally.
from VOA News October 14, 2020
“No matter how you slice it, there's uncertainty, and there are costs and benefit trade-offs. That sounds perhaps to some a little bit crass, but really trying to weigh the risk, what level of risk may be worth taking, and what are the costs to mitigate that risk."
from Pittsburgh Post-Gazette October 28, 2019